Technology | October 30, 2008

Vivid E9 Aims for Endocardial Definition


GE Healthcare’s recently released Vivid E9 ultrasound features Accelerated Volume Architecture (AVA), which not only makes single beat acquisition possible but, working alongside Extended Signal transducer technology in each probe, it reportedly delivers a leap in 2D, 4D and shared service image quality across the entire patient population.

The new M5S transducer takes the matrix array technology and marries this with single crystal technology to reportedly provide better endocardial definition, texture and crisper valves across a wider range of frequencies than traditional transducers.


Additional Content

News | Cardiovascular Ultrasound

Oct. 12, 2026 — Siemens Healthineers announced it ultrasound business plans to concentrate its efforts on cardiovascular ...

Home October 12, 2026
Home
News | Cardiovascular Ultrasound

Aug. 28, 2026 — GE HealthCare has announced three additions to its Vivid cardiovascular ultrasound portfolio — Vivid ...

Home August 28, 2026
Home
News | Cardiovascular Ultrasound

Aug. 11, 2026 — Bracco Imaging recently announced that VueJect, its dedicated ultrasound contrast delivery system ...

Home August 11, 2026
Home
News | Cardiovascular Ultrasound

April 29, 2026 — Agitated Solutions, Inc.(ASI) has received CE Mark approval in the European Union for its novel device ...

Home April 30, 2026
Home
Feature | Cardiovascular Ultrasound | Kyle Hardner

The demand for ultrasound has outpaced the supply of trained sonographers over the past 15 years, straining hospital ...

Home March 11, 2026
Home
Subscribe Now